⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Mercodia AB and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Mercodia AB
↗Uppsala, Sweden
Mercodia is a Swedish life science company and a premier bioanalytical Contract Research Organization (CRO) specializing in cardiometabolic diseases. Founded in 1991, the company leverages its heritage in immunoassay development to provide high-quality ELISA kits and comprehensive bioanalytical services to support drug development from preclinical through clinical phases.
Mercodia operates GLP-compliant laboratories in Sweden and the United States, offering expertise in pharmacokinetics, pharmacodynamics, immunogenicity, and biomarker analysis. The company is a trusted partner to over 200 research organizations, CROs, and pharmaceutical companies worldwide, known for its rigorous quality standards and regulatory consultancy.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Founded:1991
Ownership:private
Status:operating
PIPELINE
Modalities:Biologics, Peptides, Oligonucleotides, Antibodies
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Mercodia Inc (USA)
Key Partnerships:Collaborates with academic institutions and global pharma/biotech companies for assay development and validation.
COMPETITION
Position:Niche Player
Competitors:Meso Scale Diagnostics (MSD), Other specialized bioanalytical CROs
LEADERSHIP
Key Executives:
Erling Holmlund - Founder
Scientific Founders:Erling Holmlund
LINKS
Website:mercodia.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Mercodia AB. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.